HUP0004507A3 - Use of ketolides preparing arterial thrombotic complications related to atherosclerosis - Google Patents

Use of ketolides preparing arterial thrombotic complications related to atherosclerosis

Info

Publication number
HUP0004507A3
HUP0004507A3 HU0004507A HUP0004507A HUP0004507A3 HU P0004507 A3 HUP0004507 A3 HU P0004507A3 HU 0004507 A HU0004507 A HU 0004507A HU P0004507 A HUP0004507 A HU P0004507A HU P0004507 A3 HUP0004507 A3 HU P0004507A3
Authority
HU
Hungary
Prior art keywords
ketolides
atherosclerosis
complications related
thrombotic complications
arterial thrombotic
Prior art date
Application number
HU0004507A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HUP0004507A1 publication Critical patent/HUP0004507A1/hu
Publication of HUP0004507A3 publication Critical patent/HUP0004507A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HU0004507A 1997-11-17 1998-11-16 Use of ketolides preparing arterial thrombotic complications related to atherosclerosis HUP0004507A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (2)

Publication Number Publication Date
HUP0004507A1 HUP0004507A1 (hu) 2001-05-28
HUP0004507A3 true HUP0004507A3 (en) 2001-12-28

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004507A HUP0004507A3 (en) 1997-11-17 1998-11-16 Use of ketolides preparing arterial thrombotic complications related to atherosclerosis

Country Status (35)

Country Link
US (1) US20080139489A1 (enExample)
EP (1) EP1030673B1 (enExample)
JP (1) JP4550273B2 (enExample)
KR (1) KR20010032130A (enExample)
CN (1) CN1286633A (enExample)
AP (1) AP1196A (enExample)
AR (1) AR014119A1 (enExample)
AT (1) ATE271875T1 (enExample)
AU (1) AU744419B2 (enExample)
BG (1) BG104427A (enExample)
BR (1) BR9814199A (enExample)
CA (1) CA2312021C (enExample)
DE (1) DE69825308T2 (enExample)
DZ (1) DZ2654A1 (enExample)
EA (1) EA003322B1 (enExample)
EE (1) EE04095B1 (enExample)
ES (1) ES2224446T3 (enExample)
FR (1) FR2771008B1 (enExample)
GE (1) GEP20032968B (enExample)
HR (1) HRP20000314A2 (enExample)
HU (1) HUP0004507A3 (enExample)
ID (1) ID24940A (enExample)
IL (1) IL136149A0 (enExample)
MA (1) MA26566A1 (enExample)
NO (1) NO20002435L (enExample)
NZ (1) NZ504305A (enExample)
OA (1) OA11411A (enExample)
PL (1) PL340373A1 (enExample)
SK (1) SK7042000A3 (enExample)
TN (1) TNSN98206A1 (enExample)
TR (1) TR200001384T2 (enExample)
TW (1) TW472061B (enExample)
WO (1) WO1999025365A1 (enExample)
YU (1) YU29600A (enExample)
ZA (1) ZA9810357B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
WO2000034297A1 (en) 1998-12-10 2000-06-15 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
AU1675400A (en) * 1999-01-27 2000-08-18 Pfizer Products Inc. Ketolide antibiotics
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
ATE437860T1 (de) 2000-04-04 2009-08-15 Smithkline Beecham Plc 2-hydroxy-mutilin-carbamat derivate und ihre anwendung als antibakterielle mittel
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
EP2613630A4 (en) * 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022819A1 (en) * 1991-06-14 1992-12-23 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
FR2771008A1 (fr) 1999-05-21
TR200001384T2 (tr) 2001-06-21
JP4550273B2 (ja) 2010-09-22
EA003322B1 (ru) 2003-04-24
NZ504305A (en) 2002-11-26
CA2312021C (fr) 2008-08-26
BR9814199A (pt) 2000-09-26
OA11411A (fr) 2004-04-20
AR014119A1 (es) 2001-02-07
DE69825308D1 (de) 2004-09-02
CA2312021A1 (fr) 1999-05-27
IL136149A0 (en) 2001-05-20
CN1286633A (zh) 2001-03-07
DE69825308T2 (de) 2005-08-04
HUP0004507A1 (hu) 2001-05-28
EP1030673A1 (fr) 2000-08-30
NO20002435D0 (no) 2000-05-11
MA26566A1 (fr) 2004-12-20
TNSN98206A1 (fr) 2005-03-15
US20080139489A1 (en) 2008-06-12
TW472061B (en) 2002-01-11
AU1242599A (en) 1999-06-07
EA200000531A1 (ru) 2000-10-30
EE04095B1 (et) 2003-08-15
HRP20000314A2 (en) 2001-02-28
NO20002435L (no) 2000-07-07
SK7042000A3 (en) 2000-12-11
DZ2654A1 (fr) 2003-03-22
AP1196A (en) 2003-08-18
WO1999025365A1 (fr) 1999-05-27
AU744419B2 (en) 2002-02-21
KR20010032130A (ko) 2001-04-16
YU29600A (sh) 2003-02-28
ES2224446T3 (es) 2005-03-01
FR2771008B1 (fr) 2000-04-28
PL340373A1 (en) 2001-01-29
EP1030673B1 (fr) 2004-07-28
ATE271875T1 (de) 2004-08-15
AP2000001825A0 (en) 2000-06-30
ID24940A (id) 2000-08-31
BG104427A (en) 2001-02-28
JP2001523644A (ja) 2001-11-27
GEP20032968B (en) 2003-05-27
ZA9810357B (en) 1999-11-12
EE200000244A (et) 2001-06-15

Similar Documents

Publication Publication Date Title
HUP0104031A3 (en) Novel process to prepare microencapsulated formulations
EP0693804A3 (en) Connector between two printed circuit boards
EG20950A (en) Manufacture of surfactant esters
GB9722733D0 (en) Production of esters
IL127421A0 (en) Process to prepare aryldiphosphoric esters
HUP0004507A3 (en) Use of ketolides preparing arterial thrombotic complications related to atherosclerosis
AUPM874394A0 (en) Improvements to brick walls
ZA9510182B (en) Preparation of confections
ZA9510785B (en) Use of lauric esters as activity-increasing substa
GB9710953D0 (en) Improvements relating to methods of constructing walls
GB9504028D0 (en) Additive to expanded foam
GB9001524D0 (en) Improvements in or relating to the synchronization of video signals
IL122919A0 (en) Preparation of 1-alkyl-pyrazole-5-carboxylic acid esters
PL330729A1 (en) Improvement related to aqueous bleaching compositions
GB9607162D0 (en) Improvements in or relating to the transmission of data
GB2308967B (en) Equipment relating to bleeding of fish
GB9827806D0 (en) Improvements relating primarily to sound & lighting mixing consoles
GB9726247D0 (en) Preparation of esters
GB9726246D0 (en) Preparation of esters
ZA983900B (en) Process to 5-methyleneoxazolenes
GB9615604D0 (en) Improvements relating to methods of constructing walls
GB9618396D0 (en) Improvements relating to methods of constructing walls
GB9612759D0 (en) Improvements relating to pendants
GB9519441D0 (en) Improvements relating to buildings
TW308026U (en) Improved structure of decoration demonstration-stage